Chemotactic action of prostaglandin E <sub>2</sub> on mouse mast cells acting via the PGE <sub>2</sub> receptor 3
Charlotte Weller(Asthma UK), Timothy J. Williams(Arizona State University), Jane E. Barker(National Institutes of Health), Graham W. Taylor(Vector Institute), Sarah J. Collington(National Institutes of Health), Toshihiko Kaise(National Institutes of Health), Peter J. Jose(National Institutes of Health), Adele Hartnell(John Radcliffe Hospital), Dolores M. Conroy(University College London), Mark S. Wilson(Gene Therapy Laboratory)
Cited by 131
Related Papers
Type 2 immunity in tissue repair and fibrosis
|Nature reviews. Immunology|2017|1.1k
Pulmonary fibrosis: pathogenesis, etiology and regulation
|Mucosal Immunology|2009|834
Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
|PLoS Pathogens|2009|808
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
|The Journal of Experimental Medicine|2010|740
Suppression of allergic airway inflammation by helminth-induced regulatory T cells
|The Journal of Experimental Medicine|2005|609